维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Gulseth"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Rivaroxaban: an oraJ direct inhibitor of factor Xa显示文摘	GULSETH MP MICHAUD J NUTESCU EA	2008	AM J Health pharm2008，65，16：	1
2	Vitamin D and the Metabolic Syndrome显示文摘	Hanne L. Gulseth Ingrid M.F. Gjelstad Kare I. Birkeland Christian A. Drevon	2013	Current Vascular Pharmacology2013，，6：	1
3	Rivaroxaban: An oral direct inhibitor of factor Ⅹ a 显示文摘	Gulseth MP Mchaud J Nutescu EA	2008	Am J Health Syst Pharm2008，65，16：	1
4	Rivaroxaban: an oral direct inhibitor of factor Xa显示文摘	GULSETH MP MICHAUD J NUTESCU EA	2008	Am J Health Pharm2008，65，16：	1
5	Inpatient warfarin:experience with a pharmacistled anticoagulation management service in a tertiary care medical center显示文摘	FOWLER S GULSETH M P	2012	Am J Health Syst Pharm2012，69，1：	1
6	Rivaroxaban : An oral direct inhibitor of factor Xa显示文摘	Gulseth MP Michaud J Nutescu EA	2008	Am J Health Syst Pharm2008，65，16：	1
7	New oral therapies for the prevention and treatment of venous thromboembolism显示文摘	HELLWIG T GULSETH M	2013	Am J Health Syst Pharm2013，70，2：	1
8	Implementing anticoagulation management by pharmacists in the inpatient setting显示文摘	Dager WE Gulseth MP	2007	Am J Health-Syst Phann2007，64，10：	1
9	Implementing anticoagulation management by pharmacists in the inpatient setting显示文摘	Dager WE Gulseth MP	2007	Am J Health Syst Pharm2007，64，10：	1
10	Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes显示文摘	Wium C Gulseth HL Eriksen EF	2013	PLoS One2013，8，83：	1
11	Rivaroxaban:an oral direct inhibitor of factor Ⅹa显示文摘	Gulseth MP Michaud J Nutescu EA	2008	Am J Health Syst Pharm2008，65，16：	1
12	Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation显示文摘	Hellwig T Gulseth M	2013	Ann Pharmacother2013，47，：	1
13	Rivaroxaban: An oral direct inhibitor of factor Xa显示文摘	Michael P. Gulseth Jessica Michaud Edith A. Nutescu	2008	American Journal of Health-System Pharmacy2008，，16：	1
14	Inpatient warfarin : expe- rience with a pharmacist-led anticoagulation management service in a tertiary care medical center 显示文摘	Fowler S Gulseth MP Renier C	2012	Am J Health Syst Pharm2012，69，1：	1
15	Rivaroxaban: an oral direct inhibitor of factor Xa显示文摘	GULSETH MP MICHAUD J NUTESCU EA	2008	Am J Health Syst Pharm2008，65，16：	1
16	Rivaroxaban : an oral direct inhibitor of factor Xa 显示文摘	Gulseth MP Michaud J Nutescu EA	2008	Am J Health Syst Pharm2008，65，16：	1
17	Serum vitamin D concentration does not predict insulin action or secretion in European subiects with the metabolic syndrome显示文摘	Gulseth HL Gjelstad IM Tierney AC at al		Diabetes Care0，33，4：	1
18	One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events 显示文摘	Chert SY Wu N Gulseth M	2013	J Manag Care Pharm2013，19，4：	1
19	Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery显示文摘	Gulseth MP Grice GR Dager WE	2009	American Journal of Health-System Pharmacy2009，66，2：	1
20	The effects of acute and chronic exercise on PGC ‐1α, irisin and browning of subcutaneous adipose tissue in humans显示文摘	Frode Norheim Torgrim Mikal Langleite Marit Hjorth Torgeir Holen Anders Kielland Hans Kristian Stadheim Hanne L?vdal Gulseth K?re Inge Birkeland J?rgen Jensen Christian A. Drevon	2014	FEBS J2014，，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示